Living Document · Updated June 2026
Cardio-Oncology
Living Guideline
Based on 2022 ESC Guidelines · Continuously updated
Introduction
June 2026
This living guideline is organized to mirror the structure of the 2022 European Society of Cardiology (ESC) Cardio‑Oncology Guidelines. Each section summarises the original guidance and incorporates new high‑quality evidence published after 2022. The purpose is to provide clinicians and researchers with an evolving reference that reflects current best practices in cardio‑oncology.
Living Document
This is a living guideline. Content is updated periodically as new high-quality evidence becomes available. Last comprehensive review: June 2026.